Back

dr. R. (Rob) Kessels

dr. R. (Rob) Kessels

Assistant Professor
dr. R. (Rob) Kessels
  • Julius Center, dept. Epidemiology & Health Economics

Research Programs

Cancer

Biography

Biography

I am clinical trial methodology researcher and biostatistician working at the Clinical Trial Methodology and Statistical Consultation group within the Department of Data Science and Biostatistics at the Julius Center. My research is focused on developing and implementing innovative (early-phase) adaptive clinical trials within Oncode Accelerator. I am also involved in the design, methodology, and analysis of (oncology) clinical trials. 

Before joining the UMC Utrecht, I worked as a statistician at the Antoni van Leeuwenhoek hospital/Netherlands Cancer Institute focusing on design and analysis of oncology clinical trials and I was involved in the Dutch Oncology Research Platform (DORP), an initiative to support investigator initiated clinical research. 

I hold a PhD degree in Statistics from Utrecht University (2022) and a MSc degree in Methodology and Statistics for the Behavioural, Biomedical and Social Sciences from Utrecht University (2014). 

Research Output (11)

MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II-III HER2-positive breast cancer (TRAIN-3):a multicentre, single-arm, phase 2 study

van der Voort Anna, Louis Fleur M, van Ramshorst Mette S, Kessels Rob, Mandjes Ingrid A, Kemper Inge, Agterof Mariette J, van der Steeg Wim A, Heijns Joan B, van Bekkum Marlies L, Siemerink Ester J, Kuijer Philomeen M, Scholten Astrid, Wesseling Jelle, Vrancken Peeters Marie-Jeanne T F D, Mann Ritse M, Sonke Gabe S, May 2024, In: LANCET ONCOLOGY. 25 , p. 603-613 11 p.

Phase I feasibility study of Olaparib in combination with loco-regional radiotherapy in head and neck squamous cell carcinoma

Navran Arash, Al-Mamgani Abrahim, Elzinga Hester, Kessels Rob, Vens Conchita, Tesselaar Margot, van den Brekel Michiel, de Haan Rosemarie, van Triest Baukelien, Verheij Marcel Jan 2024, In: Clinical and translational radiation oncology. 44 , p. 100698

High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer:the randomized phase III NeoTN trial

Vliek Sonja, Hilbers Florentine S, van Werkhoven Erik, Mandjes Ingrid, Kessels Rob, Kleiterp Sieta, Lips Esther H, Mulder Lennart, Kayembe Mutamba T, Loo Claudette E, Russell Nicola S, Vrancken Peeters Marie-Jeanne T F D, Holtkamp Marjo J, Schot Margaret, Baars Joke W, Honkoop Aafke H, Vulink Annelie J E, Imholz Alex L T, Vrijaldenhoven Suzan, van den Berkmortel Franchette W P J, Meerum Terwogt Jetske M, Schrama Jolanda G, Kuijer Philomeen, Kroep Judith R, van der Padt-Pruijsten Annemieke, Wesseling Jelle, Sonke Gabe S, Gilhuijs Kenneth G A, Jager Agnes, Nederlof Petra, Linn Sabine C Dec 2023, In: npj Breast Cancer. 9

Adaptive FDG-PET/CT guided dose escalation in head and neck squamous cell carcinoma:Late toxicity and oncologic outcomes (The ADMIRE study)

Al-Mamgani Abrahim, Kessels Rob, Gouw Zeno A R, Navran Arash, Mohan Vineet, van de Kamer Jeroen B, Sonke Jan-Jakob, Vogel Wouter V Nov 2023, In: Clinical and translational radiation oncology. 43

The Trial within Cohorts (TwiCs) study design in oncology:experience and methodological reflections

Kessels Rob, May Anne M, Koopman Miriam, Roes Kit C B 13 May 2023, In: BMC Medical Research Methodology. 23

Self-Reported Cognitive Function and Quality of Life in Patients With SCLC in the Hippocampal Avoidance Prophylactic Cranial Irradiation Versus Prophylactic Cranial Irradiation Randomized Phase 3 Trial (NCT01780675)

Albers Elaine A C, Zeng Haiyan, De Ruysscher Dirk K M, Kuenen Marianne A, Kessels Rob, Hendriks Lizza E L, Belderbos Jose S A, Schagen Sanne B May 2023, In: JTO clinical and research reports. 4 , p. 100506

Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma. Reply

Rohaan Maartje W, Kessels Rob, Haanen John B A G 2 Mar 2023, In: The New England journal of medicine. 388 , p. 859-860 2 p.

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

Rohaan Maartje W et al. 8 Dec 2022, In: The New England journal of medicine. 387 , p. 2113-2125 13 p.

Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer

van Nassau Sietske C, Bond Marinde J, Scheerman Ilva, van Breeschoten Jesper, Kessels Rob, Valkenburg-van Iersel Liselot B, Verheul Henk M, Buffart Tineke E, Mekenkamp Leonie J, Lemmens Valery E, Koopman Miriam, Bol Guus M, 10 Sep 2021, In: JAMA network open. 4

Retrospective analyses of 18FDG-PET/CT thyroid incidentaloma in adults:incidence, treatment and outcome in a tertiary cancer referral center

Piek Marceline W, de Boer Jan Paul, Vriens Menno R, van Leeuwaarde Rachel S, Stokkel Marcel, Hartemink Koen J, van Duijnhoven Frederieke, Kessels Rob, van der Ploeg Iris M C 3 Sep 2021, In: Thyroid. 31 , p. 1715-1722 8 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not